CVS

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade CVS 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About CVS

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. 

CEO
J. David Joyner
CEOJ. David Joyner
Employees
300,000
Employees300,000
Headquarters
Woonsocket, Rhode Island
HeadquartersWoonsocket, Rhode Island
Founded
1963
Founded1963
Employees
300,000
Employees300,000

CVS Key Statistics

Market cap
125.09B
Market cap125.09B
Price-Earnings ratio
42.62
Price-Earnings ratio42.62
Dividend yield
2.74%
Dividend yield2.74%
Average volume
7.81M
Average volume7.81M
High today
$98.60
High today$98.60
Low today
$96.15
Low today$96.15
Open price
$97.57
Open price$97.57
Volume
8.73M
Volume8.73M
52 Week high
$98.61
52 Week high$98.61
52 Week low
$58.50
52 Week low$58.50

Stock Snapshot

As of today, CVS(CVS) shares are valued at $98.05. The company's market cap stands at 125.09B, with a P/E ratio of 42.62 and a dividend yield of 2.7%.

As of 2026-06-11, CVS(CVS) stock has fluctuated between $96.15 and $98.60. The current price stands at $98.05, placing the stock +2.0% above today's low and -0.6% off the high.

The CVS(CVS)'s current trading volume is 8.73M, compared to an average daily volume of 7.81M.

In the last year, CVS(CVS) shares hit a 52-week high of $98.61 and a 52-week low of $58.50.

In the last year, CVS(CVS) shares hit a 52-week high of $98.61 and a 52-week low of $58.50.

CVS News

Investing.com 17h
CVS Health expands GLP-1 coverage, adds Zepbound to formulary - Investing.com

...

CVS Health expands GLP-1 coverage, adds Zepbound to formulary - Investing.com
Simply Wall St 1d
CVS Health Lawsuits Test 340B Practices And Undervaluation Narrative

CVS Health is facing major lawsuits from hospital systems over alleged diversion of federal 340B drug discount program funds. The cases target the pharmacy ben...

CVS Health Lawsuits Test 340B Practices And Undervaluation Narrative
24/7 Wall St. 3d
These 3 'Old Economy' Dow Stocks Are Quietly Crushing the Market, and Here's What They All Share

These 3 ‘Old Economy’ Dow Stocks Are Quietly Crushing the Market, and Here’s What They All Share By Trey Thoelcke Published Jun 8, 9:15AM EDT Quick Read These...

These 3 'Old Economy' Dow Stocks Are Quietly Crushing the Market, and Here's What They All Share

Analyst ratings

83%

of 29 ratings
Buy
82.8%
Hold
17.2%
Sell
0%

More CVS News

Nasdaq 6d
CVS Health Just Announced Fantastic News to Eli Lilly Stock Investors

Key Points CVS Caremark will cover Eli Lilly's weight loss medicines. This decision could help boost the drugmaker's sales. Eli Lilly's prospects remain attr...

CVS Health Just Announced Fantastic News to Eli Lilly Stock Investors
TipRanks 7d
CVS Health price target raised to $111 from $106 at Morgan Stanley

Morgan Stanley raised the firm’s price target on CVS Health (CVS) to $111 from $106 and keeps an Overweight rating on the shares. Managed care stocks have been...

People also own

Based on the portfolios of people who own CVS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.